MICIACCIA, MORENA
 Distribuzione geografica
Continente #
NA - Nord America 1.305
AS - Asia 1.281
EU - Europa 833
SA - Sud America 301
AF - Africa 50
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.798
Nazione #
US - Stati Uniti d'America 1.242
SG - Singapore 512
IT - Italia 374
CN - Cina 254
BR - Brasile 227
HK - Hong Kong 170
RU - Federazione Russa 93
VN - Vietnam 88
DE - Germania 77
GB - Regno Unito 53
SE - Svezia 52
IN - India 50
CA - Canada 41
FR - Francia 37
JP - Giappone 32
NL - Olanda 27
AU - Australia 26
FI - Finlandia 24
ID - Indonesia 24
TR - Turchia 22
AR - Argentina 19
BD - Bangladesh 19
EC - Ecuador 18
CH - Svizzera 14
IQ - Iraq 13
KR - Corea 13
MX - Messico 13
ZA - Sudafrica 13
CI - Costa d'Avorio 12
CO - Colombia 11
ES - Italia 11
SA - Arabia Saudita 11
BE - Belgio 10
PH - Filippine 10
PL - Polonia 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
CL - Cile 8
AT - Austria 7
IR - Iran 7
LT - Lituania 7
PK - Pakistan 7
VE - Venezuela 6
HU - Ungheria 5
IE - Irlanda 5
IL - Israele 5
PY - Paraguay 5
TW - Taiwan 5
EG - Egitto 4
KE - Kenya 4
MA - Marocco 4
NO - Norvegia 4
NP - Nepal 4
PE - Perù 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
SN - Senegal 3
TH - Thailandia 3
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
TN - Tunisia 2
TZ - Tanzania 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
FJ - Figi 1
GI - Gibilterra 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SR - Suriname 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 3.798
Città #
Singapore 263
Ashburn 218
San Jose 177
Hong Kong 164
Beijing 92
Bari 65
Sannicandro di Bari 57
Dallas 54
Chandler 48
Los Angeles 40
Nyköping 39
Fairfield 37
New York 36
Ho Chi Minh City 35
Council Bluffs 32
Helsinki 24
São Paulo 23
Cambridge 21
Tokyo 21
Falkenstein 20
Milan 19
Munich 18
Frankfurt am Main 17
Houston 17
Lauterbourg 17
Woodbridge 16
San Francisco 15
Toronto 15
Jakarta 14
Santa Clara 14
Seattle 14
Rome 13
Abidjan 12
Hanoi 12
London 12
Brussels 10
Catania 10
Denver 10
Tashkent 10
Waltham 10
Warsaw 10
Wilmington 10
Bitonto 9
Boardman 9
Montreal 9
New Delhi 9
Nuremberg 9
Brno 8
Santiago 8
Shanghai 8
West Lafayette 8
Ann Arbor 7
Belo Horizonte 7
Bern 7
Brooklyn 7
Buffalo 7
Burlington 7
Chennai 7
Chuncheon 7
City of London 7
Florence 7
Guayaquil 7
Johannesburg 7
Orem 7
Palo Alto 7
Atlanta 6
Brisbane 6
Chicago 6
Düsseldorf 6
Lawrence 6
Lecce 6
Mersin 6
Mexico City 6
Mumbai 6
Perth 6
Philadelphia 6
Phoenix 6
Prineville 6
Stockholm 6
Sydney 6
Dearborn 5
Forest City 5
Jeddah 5
Medellín 5
Moscow 5
Petaluma 5
Quito 5
Riyadh 5
Roxbury 5
Warrington 5
Adelaide 4
Altamura 4
Amsterdam 4
Arequipa 4
Baghdad 4
Boston 4
Des Moines 4
Fort Worth 4
Fragagnano 4
Haiphong 4
Totale 2.116
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 236
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment 173
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid 153
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection 149
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior 127
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders 122
DECONSTRUCTING ONC201 TO DESIGN NEW MITOCHONDRIAL ClpP ACTIVATORS FOR PEDIATRIC H3K27-ALTERED DIFFUSE MIDLINE GLIOMA 116
MODULATORS OF HUMAN MITOCHONDRIAL PROTEASE ClpP ACTIVITY FOR PEDIATRIC DIFFUSE PONTINE GLIOMA TREATMENT 110
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer 107
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery 105
STRUCTURAL EVOLUTION OF ONC201-DERIVED COMPOUNDS TARGETING THE MITOCHONDRIAL PROTEASE CLPP FOR PEDIATRIC DIFFUSE MIDLINE GLIOMA H3K27-ALTERED" 102
Comparative Structural Analysis of hCOX‑1 and oCOX‑1 Isoenzymes 102
Three-dimensional structure of human cyclooxygenase (hCOX)-1 96
m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity 92
Patient Bone Marrow Aspiration to Explore the Cyclooxygenases (COXs) Involvement in Multiple Myeloma 90
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment 87
TARGETING HUMAN MITOCHONDRIAL ClpP AS A NOVEL THERAPEUTIC APPROACH TO H3K27-ALTERED DIFFUSE MIDLINE GLIOMA 87
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19 83
A Simplified Direct O2 Consumption-Based Assay to Test COX Inhibition 83
Ovine COX-1 Isoenzyme Bio-production 83
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes 81
Novel hClpP protease activators with potential anticancer activity in DIPG patients 80
Modulation of the activity of human mitochondrial protease complex ClpXP as potential therapeutic strategy for cancer 80
Neuroinflammation and Microglial Constitutive COX-1 Inhibition 77
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG) 75
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER 75
Human Caseinolytic Protease P (hClpP) Activity Modulating Agents For The Treatment Of DIPG/DMG 74
Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges 70
Structure-activity relationships of piperazine-2-one derivatives as novel human ClpP activators 68
Inside circular economy challenges: “green” application to valorise olive mill wastewater 67
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy 64
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel mediated resistance in gastric cancer cell lines 61
Design and synthesis of new [4,5-b] and [4,5-c] imidazopyridines as potential fluorophores/inhibitors for Human Cyclooxygenase-1. 61
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design 61
The Tyrosine Kinases Inhibitors (TKI) Staurosporine/Midostaurin Act as Cation Channel Inhibitors with Antiproliferative Effects in DIPG36 and DIPG50 cells 60
DIPG-27. Diffuse Intrinsic Pontine Glioma (DIPG) challenge: from gene expression profile to drug. 60
Can Focused Ultrasound Overcome the Failure of Chemotherapy in Treating Pediatric Diffuse Intrinsic Pontine Glioma Due to a Blood–Brain Barrier Obstacle? 59
Mitochondrial Protease ClpP: Cancer Marker and Drug Target 53
Potassium channels and TRPV1 modulators on SU-DIPG-36 and SU-DIPG-50 cells: in vitro effects and channel currents characterization 52
Three-dimensional structure of human cyclooxygenase (hCOX)-1 51
Exosomes in Ovarian Cancer: Towards Precision Oncology 49
Structural simplification of imipridones to speed up the knowledge on the nature of the interactions with the human ClpP, a mitochondrial protease strictly linked to DIPG 46
Harmaline as novel mitochondrial human ClpP activator for the treatment of pediatric DIPG 44
Effect of microbial fermentation on functional traits and volatiloma profile of pâté olive cake 37
ONC201-derived Tetrahydropyridopyrimidindiones as powerful ClpP protease activators to tackle diffuse midline glioma 37
KATP Channel Inhibitors Reduce Cell Proliferation Through Upregulation of H3K27ac in Diffuse Intrinsic Pontine Glioma: A Functional Expression Investigation 35
Olive Mill Wastewater Fermented with Microbial Pools as a New Potential Functional Beverage 34
Triazole-benzodiazepine derivatives: One-pot synthesis, characterization, hirshfeld surface analysis, and computational insights into anticancer potential as KIF11 inhibitors 21
Size-Controlled Mesoporous Silica Nanoparticles via Template Nanoarchitectonics from a Deferoxamine Derivative for Enhanced Blood–Brain Barrier Permeability and Neuroprotective Chelation Therapy 19
Therapeutic Role of Cyclooxygenase-1 (COX-1) Inhibition, Challenging the Conventional View of COX-1 as Purely Constitutive 16
Actions of Midostaurin as Cation Channel and Tyrosine Kinase Inhibitor in Diffuse Intrinsic Pontine Glioma Cell Lines 3
Totale 3.973
Categoria #
all - tutte 15.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 15 7 4
2021/202275 10 6 1 2 2 5 2 14 3 8 9 13
2022/2023152 8 19 17 6 18 21 4 27 19 4 6 3
2023/2024295 4 14 14 24 26 18 16 7 95 35 16 26
2024/2025924 41 14 40 35 68 78 150 86 47 60 88 217
2025/20262.339 274 105 183 263 333 154 299 126 363 239 0 0
Totale 3.973